NeOnc Technologies Holdings, Inc. (Nasdaq Global Market: NTHI), a clinical-stage medical biotechnology company, today announced a strategic partnership with CBCC Global Research (CBCC), a premier full ...

An 18-year-old has revealed how she was tested for countless illnesses throughout 2024 until an unusual symptom exposed the ...

Doctors eventually discovered she had a type of glioma brain tumour called IDH1 mutation astrocytoma. It is typically classed as stage one or two, but a small portion of Ms Barbara’s tumour had ...

The drug candidate – called vorasidenib – is a dual inhibitor of mutated IDH1 and IDH2, which is being developed for a hard-to-treat form of brain cancer called glioma. It was acquired by ...

Published recently in the journal Frontiers in Nutrition, the report is the first evaluation of the use of ketogenic metabolic therapy (KMT) without chemo or radiation interventions, on a patient ...

DelveInsight’s, “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline ...

A young British woman who used to drink 12 cups of coffee a day and quit because of some caffeine withdrawal symptoms like ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...